Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$256.26
+1.34%
Mkt Cap $37.27B
Analyst Ratings
Buy
22
Hold
9
Sell
0
Price Target (146 analysts)
$245.88
Range $175.00 – $300.00
Implied Upside
-4.1%
Consensus $245.88 vs current $256.26